Severe egg allergy? There's now a flu shot for you

by Mike Stobbe

People with serious egg allergies may no longer have to worry about flu shots.

A federal advisory panel on Thursday said a new vaccine that's made without eggs is an option for adults with severe allergies. Current flu shots are made from viruses grown in eggs and could trigger allergic reactions in some cases.

The new Flublok vaccine is made with , which is used for other kinds of vaccines. It was licensed in January by Protein Sciences Corp.

Officials don't know how many Americans skip flu shots because they're allergic to eggs.

About 1 in 66 children have , though most kids outgrow them. The new vaccine is not an option for kids. So far it's licensed only for adults ages 18 to 49.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Kids fight food allergies one bite at a time

Dec 27, 2012

(Medical Xpress)—The holidays can be a stressful time for parents of the six million children in the United States with food allergies.  With so many parties and gifts involving food, parents may worry that their children ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments